Gilead Sciences GILD
NASDAQ GILD
$149.05 -2.23 (-1.47%)
At close: Sep 30, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Raw Materials (2009 - 2015)

Updated

Gilead Sciences' Raw Materials was $1.33 billion in Q4 2015, up 46.5% from $909 million a year earlier.

Analysis

Gilead Sciences (GILD) Raw Materials (2009 - 2015) Analysis & Trends

From Q4 2009 onward, Gilead Sciences has reported Raw Materials for 12 quarters.

  • Raw Materials shows a five-year compound annual growth rate of 26.7% (FY2010 to FY2015).
  • In earlier years, Raw Materials was $909 million in FY2014 (-13.4%), $1.05 billion in FY2013 (+27.0%), $826.55 million in FY2012 (+18.5%) and $697.62 million in FY2011 (+71.0%).
  • The Q4 2015 figure marks the highest quarterly Raw Materials in data going back to Q4 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 1.33 Bn
Dec 31, 2014 909.00 Mn
Jun 30, 2014 944.89 Mn
Dec 31, 2013 1.05 Bn
Dec 31, 2012 826.55 Mn
Dec 31, 2011 697.62 Mn
Sep 30, 2011 866.41 Mn
Jun 30, 2011 665.25 Mn
Mar 31, 2011 559.16 Mn
Dec 31, 2010 408.02 Mn
Sep 30, 2010 441.53 Mn
Dec 31, 2009 333.58 Mn
API Access

Gilead Sciences Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=GILD&period=max&api_key=YOUR_API_KEY